The invention relates in particular to antisense oligonucleotides that modulate the expression and / or function of sialidase 4 (NEU4) by targeting natural antisense polynucleotides of sialidase 4 (NEU4). The invention also relates to their use in the treatment of diseases and disorders associated with the identification of these antisense oligonucleotides and the expression of sialidase 4 (NEU4).
展开▼